Quality & complianceOfficial
Health Canada recalls two Taro-Candesartan 8 mg lots that may contain esomeprazole capsules
🇨🇦 Health Canada · Mon 16 Nov 2026
A Type II recall covers two lots of candesartan tablets distributed nationally in Canada, which may contain esomeprazole 20 mg capsules.
Health Canada has published a Type II recall for two lots of Taro-Candesartan 8 mg tablets. The notice, last updated on 16 November 2026, says the affected lots may contain Esomeprazole 20 mg capsules. The issue is classed as a product quality problem.
Subscribe to keep reading
$4.99 / month
- Every article, analysis and opinion piece on VigiEye and CompePharma
- One subscription for both sites, cancel any time
or
Official source: Health Canada ↗
Article written by VigiEye from the official source (Health Canada). AI-assisted; check the source before acting.
More Quality & compliance
All →
BfArM publishes urgent field safety notice for Bentley InnoMed's BeFlow Iliac Covered Stent System
🇩🇪 BfArM field safety notices · Wed 18 Nov 2026
BfArM lists Siemens field safety notice for Dimension Urine Barbiturate Screen assay
🇩🇪 BfArM field safety notices · Wed 18 Nov 2026
BfArM publishes Medtronic MiniMed urgent field safety notice for MiniMed Go app
🇩🇪 BfArM field safety notices · Wed 18 Nov 2026
BfArM posts Merit Medical field safety notice for Philips BridgeT Balloon Prep Kit
🇩🇪 BfArM field safety notices · Wed 18 Nov 2026
BfArM posts Urgent Field Safety Notice for Biomet UK's Avantage Cup Gripper
🇩🇪 BfArM field safety notices · Wed 18 Nov 2026
BfArM publishes InterSystems field safety notice for TrakCare France software
🇩🇪 BfArM field safety notices · Wed 18 Nov 2026